Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $50M | Series A | Healthtech | United States | Investors | |
| MT Develops therapies to halt fibrosis in multiple organ systems | $76M |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| Series B |
| Biotech |
| United States |
| Investors |
| C CertHubCompany profile Uses AI-driven automation to accelerate medical device approvals and compliance Uses AI-driven automation to accelerate medical device approvals and compliance | €6.2M | Undisclosed | Healthtech | Germany | Investors |
| PS Provides AI-native due diligence for life sciences dealmaking | $20M | Series A | Biotech | United States | Investors |
| RM Rakuten MedicalCompany profile Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment | $100M | Series FSeries C+ | Biotech | United States | Investors |
| H Provides AI-powered underwriting technology for mortgage lenders | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors |
| SM Develops a Pulmonary Neuromodulation System for asthma treatment | $67M | Series A | Healthtech | United States | Investors |
| AC Provides commercial HVAC, electrical, and controls solutions | Undisclosed | Undisclosed | Proptech | United States | Investors |
| I IMVARIACompany profile Pioneers AI-driven digital biomarker solutions for clinicians to make accurate diagnoses Pioneers AI-driven digital biomarker solutions for clinicians to make accurate diagnoses | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors |
| CH Corsera HealthCompany profile Develops preventive RNAi medicines for cardiovascular disease prediction and prevention Develops preventive RNAi medicines for cardiovascular disease prediction and prevention | $80M | Series A | Healthtech | United States | Investors |